Calliditas Therapeutics AB (publ) (CALT) Stock Inclining in Premarket, Here’s why.
Calliditas Therapeutics AB (publ) (CALT) is a biotherapeutics company engaged in the development and marketing of innovative treatments for hepatic and kidney disorders. The company’s lead product is TARPEYO which is the sole therapeutics used in the reduction of proteinuria. The price of CALT stock during the regular trading on January 28, 2021, was $19.75 […]
Calliditas Therapeutics AB (publ) (CALT) Stock Inclining in Premarket, Here’s why. Read More »